BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0563 reviews
Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep
NEWSWEEK READERS’ CHOICE AWARDS 2026

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

GMATLiveTeach Starts Oct 17
Chris Peckover, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Chris Peckover, 100th-Percentile GMAT Scorer

Oct 17 · Chris Peckover
Sat · 11:00 AM to 2:00 PM ET
Oct 20 · Chris Peckover
Tue, Thu · 8:00 to 10:00 PM ET
Oct 25 · Josh Braslow
Sun · 1:00 to 4:00 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemand 5 seats left Start anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Two investigative journalists have raised the question whether the new blood pressure drug, Transerythropaxil, has

Expert replies
by BTGmoderatorDC » Mon Nov 28, 2022 12:13 am

Timer

00:00

Answers

A

B

C

D

E

Stats

Difficulty—

Two investigative journalists have raised the question whether the new blood pressure drug, Transerythropaxil, has sensitized patients to develop fish allergies. The study was published last month in a major newspaper, and has been picked up by media throughout the country. Lab data has long shown that Transerythropaxil reacts strongly with Eicosapentaenoic acid, found in abundance in fish oil, and this reaction can produce biological irritants. Despite strenuous objections from Transerythropaxil's manufacturer, scientists working in federal labs have just published papers that provide conclusive evidence to the journalists' claim.

In the argument given, the two portions in boldface play which of the following roles?


(A) The first states the conclusion of the argument; the second calls that conclusion into question.

(B) The first provides support for conclusion of the argument; the second calls that conclusion into question.

(C) The first provides support for conclusion of the argument; the second identifies the content of that conclusion

(D) The first identifies the content of the conclusion of the argument; the second provides support for that conclusion.

(E) Each provides support for the conclusion of the argument


OA D

Source: Magoosh
Join the discussion
Source: — Critical Reasoning |